We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$322M
AUM Growth
+$9.28M
Cap. Flow
+$1.33M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.21M
2
ACN icon
Accenture
ACN
+$5.86M
3
LH icon
Labcorp
LH
+$5.52M
4
EA
Electronic Arts
EA
+$5.12M
5
LRCX icon
Lam Research
LRCX
+$4.42M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.03M
2
KR icon
Kroger
KR
+$5M
3
MHK icon
Mohawk Industries
MHK
+$4.88M
4
SLB icon
SLB Ltd
SLB
+$3.51M
5
MPC icon
Marathon Petroleum
MPC
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.09%
2 Technology 14.53%
3 Industrials 11.48%
4 Communication Services 9.95%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VDC icon
176
Vanguard Consumer Staples ETF
VDC
$7.99B
-6,955
Closed -$982K
VOX icon
177
Vanguard Communication Services ETF
VOX
$5.76B
-11,095
Closed -$1.09M
VPU
178
Vanguard Utilities ETF
VPU
$8.36B
-9,635
Closed -$1.1M
GML
179
DELISTED
SPDR S&P Emerging Latin America ETF
GML
-6,350
Closed -$272K
NPP
180
DELISTED
NUVEEN PERFORMANCE+MUN FUND
NPP
-14,299
Closed -$236K
EMC
181
DELISTED
EMC CORPORATION
EMC
-50,613
Closed -$1.38M

Similar funds

Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review

As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
  • Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
  • Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
  • Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.